Apimeds Pharmaceuticals US, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Apimeds Pharmaceuticals US, Inc. reported Cash And Cash Equivalents At Carrying Value of $3.5 thousand for the year ending 2024.

  • Apimeds Pharmaceuticals US, Inc. showed a decrease of -99.2% in Cash And Cash Equivalents At Carrying Value from 2023 to 2024.
  • This data is from Apimeds Pharmaceuticals US, Inc.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
  • XBRL data for this metric is available from 2023 to 2024 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Historical annual values: Fiscal year 2024: $3.5 thousand | Fiscal year 2023: $410.5 thousand.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: